# Roper Technologies Inc: financial statements, quarterly

ROP · Nasdaq · CIK 882835 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rop.md) · [Financials](/companies/rop/financials.md) · [Filings](/companies/rop/filings.md) · [Insiders](/companies/rop/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rop/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,563](/filings/0000882835-25-000008.md) | [1,614](/filings/0000882835-25-000008.md) | [1,681](/filings/0000882835-25-000020.md) | [1,717](/filings/0000882835-25-000036.md) | [1,765](/filings/0000882835-25-000045.md) | [1,877](/filings/0000882835-25-000008.md) | [1,883](/filings/0000882835-26-000019.md) | [1,944](/filings/0000882835-26-000036.md) | [2,018](/filings/0000882835-25-000045.md) | [2,059 d](/filings/0000882835-26-000009.md) | [2,095](/filings/0000882835-26-000019.md) | [2,109](/filings/0000882835-26-000036.md) |
| Cost of revenue | $m | [467](/filings/0000882835-24-000044.md) | [488 d](/filings/0000882835-26-000009.md) | [500](/filings/0000882835-25-000020.md) | [524](/filings/0000882835-25-000036.md) | [543](/filings/0000882835-25-000045.md) | [595 d](/filings/0000882835-26-000009.md) | [589](/filings/0000882835-26-000019.md) | [598](/filings/0000882835-26-000036.md) | [615](/filings/0000882835-25-000045.md) | [629 d](/filings/0000882835-26-000009.md) | [642](/filings/0000882835-26-000019.md) | [639](/filings/0000882835-26-000036.md) |
| Gross profit | $m | [1,096](/filings/0000882835-25-000008.md) | [1,125](/filings/0000882835-25-000008.md) | [1,181](/filings/0000882835-25-000020.md) | [1,193](/filings/0000882835-25-000036.md) | [1,222](/filings/0000882835-25-000045.md) | [1,282](/filings/0000882835-25-000008.md) | [1,294](/filings/0000882835-26-000019.md) | [1,345](/filings/0000882835-26-000036.md) | [1,403](/filings/0000882835-25-000045.md) | [1,430 d](/filings/0000882835-26-000009.md) | [1,454](/filings/0000882835-26-000019.md) | [1,470](/filings/0000882835-26-000036.md) |
| Selling, general and administrative | $m | [650](/filings/0000882835-24-000044.md) | [662 d](/filings/0000882835-26-000009.md) | [700](/filings/0000882835-25-000020.md) | [699](/filings/0000882835-25-000036.md) | [725](/filings/0000882835-25-000045.md) | [758 d](/filings/0000882835-26-000009.md) | [768](/filings/0000882835-26-000019.md) | [797](/filings/0000882835-26-000036.md) | [830](/filings/0000882835-25-000045.md) | [842 d](/filings/0000882835-26-000009.md) | [884](/filings/0000882835-26-000019.md) | [886](/filings/0000882835-26-000036.md) |
| Operating income | $m | [446](/filings/0000882835-25-000008.md) | [463](/filings/0000882835-25-000008.md) | [481](/filings/0000882835-25-000020.md) | [494](/filings/0000882835-25-000036.md) | [497](/filings/0000882835-25-000045.md) | [525](/filings/0000882835-25-000008.md) | [526](/filings/0000882835-26-000019.md) | [548](/filings/0000882835-26-000036.md) | [573](/filings/0000882835-25-000045.md) | [588 d](/filings/0000882835-26-000009.md) | [570](/filings/0000882835-26-000019.md) | [585](/filings/0000882835-26-000036.md) |
| Interest expense | $m | [42.4](/filings/0000882835-23-000052.md) | [50.1 d](/filings/0000882835-24-000008.md) | [53.2](/filings/0000882835-24-000018.md) | [67.5](/filings/0000882835-24-000037.md) | [67.7](/filings/0000882835-25-000045.md) | [70.8 d](/filings/0000882835-26-000009.md) | [62.9](/filings/0000882835-26-000019.md) | [79.1](/filings/0000882835-26-000036.md) | [89.7](/filings/0000882835-25-000045.md) | [93.3 d](/filings/0000882835-26-000009.md) | [99.3](/filings/0000882835-26-000019.md) | [111](/filings/0000882835-26-000036.md) |
| Income tax | $m | [97.0](/filings/0000882835-24-000044.md) | [99.2 d](/filings/0000882835-26-000009.md) | [102](/filings/0000882835-25-000020.md) | [88.2](/filings/0000882835-25-000036.md) | [99.3](/filings/0000882835-25-000045.md) | [129 d](/filings/0000882835-26-000009.md) | [86.9](/filings/0000882835-26-000019.md) | [107](/filings/0000882835-26-000036.md) | [99.7](/filings/0000882835-25-000045.md) | [106 d](/filings/0000882835-26-000009.md) | [126](/filings/0000882835-26-000019.md) | [140](/filings/0000882835-26-000036.md) |
| Net income | $m | [347](/filings/0000882835-25-000008.md) | [389](/filings/0000882835-25-000008.md) | [382](/filings/0000882835-25-000020.md) | [337](/filings/0000882835-25-000036.md) | [368](/filings/0000882835-25-000045.md) | [462](/filings/0000882835-25-000008.md) | [331](/filings/0000882835-26-000019.md) | [378](/filings/0000882835-26-000036.md) | [399](/filings/0000882835-25-000045.md) | [428 d](/filings/0000882835-26-000009.md) | [509](/filings/0000882835-26-000019.md) | [1,169](/filings/0000882835-26-000036.md) |
| Diluted EPS | $ per share | [3.23](/filings/0000882835-25-000008.md) | [3.61](/filings/0000882835-25-000008.md) | [3.54](/filings/0000882835-25-000020.md) | [3.12](/filings/0000882835-25-000036.md) | [3.40](/filings/0000882835-25-000045.md) | [4.28](/filings/0000882835-25-000008.md) | [3.06](/filings/0000882835-26-000019.md) | [3.49](/filings/0000882835-26-000036.md) | [3.68](/filings/0000882835-25-000045.md) | not reported | [4.87](/filings/0000882835-26-000019.md) | [11.62](/filings/0000882835-26-000036.md) |
| Basic EPS | $ per share | [3.25](/filings/0000882835-25-000008.md) | [3.64](/filings/0000882835-25-000008.md) | [3.57](/filings/0000882835-25-000020.md) | [3.15](/filings/0000882835-25-000036.md) | [3.43](/filings/0000882835-25-000045.md) | [4.31](/filings/0000882835-25-000008.md) | [3.08](/filings/0000882835-26-000019.md) | [3.52](/filings/0000882835-26-000036.md) | [3.70](/filings/0000882835-25-000045.md) | not reported | [4.88](/filings/0000882835-26-000019.md) | [11.64](/filings/0000882835-26-000036.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.3](/filings/0000882835-23-000052.md) | [0.2](/filings/0000882835-25-000008.md) | [0.2](/filings/0000882835-24-000018.md) | [0.3](/filings/0000882835-24-000037.md) | [0.3](/filings/0000882835-24-000044.md) | [0.2](/filings/0000882835-26-000009.md) | [0.4](/filings/0000882835-25-000020.md) | [0.2](/filings/0000882835-25-000036.md) | [0.3](/filings/0000882835-25-000045.md) | [0.3](/filings/0000882835-26-000036.md) | [0.4](/filings/0000882835-26-000019.md) | [0.4](/filings/0000882835-26-000036.md) |
| Current assets | $bn | [1.5](/filings/0000882835-23-000052.md) | [1.5](/filings/0000882835-25-000008.md) | [1.4](/filings/0000882835-24-000018.md) | [1.5](/filings/0000882835-24-000037.md) | [1.6](/filings/0000882835-24-000044.md) | [1.5](/filings/0000882835-26-000009.md) | [1.7](/filings/0000882835-25-000020.md) | [1.7](/filings/0000882835-25-000036.md) | [1.8](/filings/0000882835-25-000045.md) | [1.9](/filings/0000882835-26-000036.md) | [1.9](/filings/0000882835-26-000019.md) | [1.9](/filings/0000882835-26-000036.md) |
| Total assets | $bn | [28.2](/filings/0000882835-23-000052.md) | [28.2](/filings/0000882835-25-000008.md) | [30.0](/filings/0000882835-24-000018.md) | [29.8](/filings/0000882835-24-000037.md) | [31.6](/filings/0000882835-24-000044.md) | [31.3](/filings/0000882835-26-000009.md) | [31.4](/filings/0000882835-25-000020.md) | [33.2](/filings/0000882835-25-000036.md) | [34.6](/filings/0000882835-25-000045.md) | [34.6](/filings/0000882835-26-000036.md) | [34.6](/filings/0000882835-26-000019.md) | [35.2](/filings/0000882835-26-000036.md) |
| Current liabilities | $bn | [2.8](/filings/0000882835-23-000052.md) | [3.0](/filings/0000882835-25-000008.md) | [2.9](/filings/0000882835-24-000018.md) | [2.8](/filings/0000882835-24-000037.md) | [3.3](/filings/0000882835-24-000044.md) | [3.8](/filings/0000882835-26-000009.md) | [3.7](/filings/0000882835-25-000020.md) | [3.6](/filings/0000882835-25-000036.md) | [3.1](/filings/0000882835-25-000045.md) | [3.7](/filings/0000882835-26-000036.md) | [3.6](/filings/0000882835-26-000019.md) | [3.5](/filings/0000882835-26-000036.md) |
| Total liabilities | $bn | [11.1](/filings/0000882835-23-000052.md) | [10.7](/filings/0000882835-25-000008.md) | [12.2](/filings/0000882835-24-000018.md) | [11.7](/filings/0000882835-24-000037.md) | [13.0](/filings/0000882835-24-000044.md) | [12.5](/filings/0000882835-26-000009.md) | [12.2](/filings/0000882835-25-000020.md) | [13.6](/filings/0000882835-25-000036.md) | [14.6](/filings/0000882835-25-000045.md) | [14.7](/filings/0000882835-26-000036.md) | [15.7](/filings/0000882835-26-000019.md) | [16.5](/filings/0000882835-26-000036.md) |
| Long-term debt | $bn | [6.4](/filings/0000882835-23-000052.md) | [5.8](/filings/0000882835-25-000008.md) | [7.2](/filings/0000882835-24-000018.md) | [6.9](/filings/0000882835-24-000037.md) | [7.7](/filings/0000882835-24-000044.md) | [6.6](/filings/0000882835-26-000009.md) | [6.5](/filings/0000882835-25-000020.md) | [7.9](/filings/0000882835-25-000036.md) | [9.2](/filings/0000882835-25-000045.md) | [8.6](/filings/0000882835-26-000036.md) | [9.7](/filings/0000882835-26-000019.md) | [10.6](/filings/0000882835-26-000036.md) |
| Current portion of debt | $bn | [0.5](/filings/0000882835-23-000052.md) | [0.5](/filings/0000882835-25-000008.md) | [0.5](/filings/0000882835-24-000018.md) | [0.5](/filings/0000882835-24-000037.md) | [0.7](/filings/0000882835-24-000044.md) | [1.0](/filings/0000882835-26-000009.md) | [1.0](/filings/0000882835-25-000020.md) | [1.0](/filings/0000882835-25-000036.md) | [0.3](/filings/0000882835-25-000045.md) | [0.7](/filings/0000882835-26-000036.md) | [0.7](/filings/0000882835-26-000019.md) | [0.7](/filings/0000882835-26-000036.md) |
| Shareholders' equity | $bn | [17.0](/filings/0000882835-24-000044.md) | [17.4](/filings/0000882835-26-000009.md) | [17.8](/filings/0000882835-25-000036.md) | [18.1](/filings/0000882835-25-000045.md) | [18.5](/filings/0000882835-25-000045.md) | [18.9](/filings/0000882835-26-000036.md) | [19.2](/filings/0000882835-26-000036.md) | [19.6](/filings/0000882835-26-000036.md) | [20.0](/filings/0000882835-25-000045.md) | [19.9](/filings/0000882835-26-000036.md) | [18.8](/filings/0000882835-26-000036.md) | [18.7](/filings/0000882835-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [630 d](/filings/0000882835-24-000044.md) | [622 d](/filings/0000882835-26-000009.md) | [532](/filings/0000882835-25-000020.md) | [384 d](/filings/0000882835-25-000036.md) | [755 d](/filings/0000882835-25-000045.md) | [722 d](/filings/0000882835-26-000009.md) | [529](/filings/0000882835-26-000019.md) | [404 d](/filings/0000882835-26-000036.md) | [870 d](/filings/0000882835-25-000045.md) | [738 d](/filings/0000882835-26-000009.md) | [592](/filings/0000882835-26-000019.md) | [470 d](/filings/0000882835-26-000036.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [72.7 d](/filings/0000882835-24-000044.md) | [72.7 d](/filings/0000882835-26-000009.md) | [80.5](/filings/0000882835-25-000020.md) | [80.1 d](/filings/0000882835-25-000036.md) | [80.5 d](/filings/0000882835-25-000045.md) | [80.8 d](/filings/0000882835-26-000009.md) | [88.6](/filings/0000882835-26-000019.md) | [88.6 d](/filings/0000882835-26-000036.md) | [88.8 d](/filings/0000882835-25-000045.md) | [89.0 d](/filings/0000882835-26-000009.md) | [97.4](/filings/0000882835-26-000019.md) | [94.0 d](/filings/0000882835-26-000036.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000882835-26-000019.md) | [0.0 d](/filings/0000882835-26-000036.md) | not reported | not reported | [1,500](/filings/0000882835-26-000019.md) | [1,227 d](/filings/0000882835-26-000036.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [107](/filings/0000882835-23-000052.md) | [107](/filings/0000882835-24-000018.md) | [107](/filings/0000882835-24-000037.md) | [108](/filings/0000882835-24-000044.md) | [108](/filings/0000882835-25-000020.md) | [108](/filings/0000882835-25-000036.md) | [108](/filings/0000882835-25-000045.md) | [108](/filings/0000882835-26-000019.md) | [108](/filings/0000882835-26-000036.md) | [108](/filings/0000882835-25-000045.md) | [105](/filings/0000882835-26-000019.md) | [101](/filings/0000882835-26-000036.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 98,900,874 at 2026-07-28, from the cover of the [10-Q filed 2026-07-31](/filings/0000882835-26-000036.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.